Weekly report of top insider buys: Stericycle Inc. (SRCL, Financial), HCC Insurance Holdings Inc. (HCC, Financial), Chico's FAS Inc. (CHS, Financial), Valeant Pharmaceuticals International (VRX, Financial), and Applied Signal Technology Inc. (APSG, Financial)
Stericycle Inc. (SRCL): Director Rodney F Dammeyer Bought 1,200 Shares
Director of Stericycle Inc., Rodney F Dammeyer, bought 1,200 shares on 9/04/2009 at an average price of $48.43.
Stericy cle Inc. is a multi-regional integrated company employing proprietary technology to provide environmentally-responsiblemanagement of regulated medical waste for the health care industry. The Company is the second-largest provider of regulated medical waste management services in the United States. Stericycle Inc. has a market cap of $4.12 billion; its shares were traded at around $48.43 with a P/E ratio of 25.62 and P/S ratio of 3.8. Stericycle Inc. had an annual average earning growth of 41.8% over the past 10 years. GuruFocus rated Stericycle Inc. the business predictability rank of 2.5-star.
On July 28, Stericycle, Inc. reported financial results for the second quarter of 2009. Revenues for the quarter ending June 30, 2009 were $289.3 million, up 4.1% from $277.8 million in the same quarter last year. Net income for the second quarter of 2009 was $43.9 million or $0.51 per diluted share compared with net income of $38.7 millionor $0.44 per diluted share for the second quarter of 2008.
Stericycle Inc. is in the portfolios of Ron Baron of Baron Funds and Ruane Cunniff of Ruane & Cunniff & Goldfarb Inc.
Sell: CFO Brink Frank Jm Ten has been selling shares of SRCL stock since June. Buy: Director Rodney F Dammeyer bought 1,200 shares of SRCL stock last week and has been buying since last month. Sell: COO Richard T Kogler sold 11,000 shares of SRCL stock in July; the price decreased over 5%.
HCC Insurance Holdings Inc. (HCC): Director Robert A Rosholt Bought 9,400 Shares
Director of HCC Insurance Holdings Inc., Robert A Rosholt, bought 9,400 shares on 9/08/2009 at an average price of $26.95.
HCC through its subsidiaries provides specialized property & casualty insurance coverages managing general agency services & insurance related services both to commercial customers & individuals. HCC's insurance products are underwritten on both a direct & reinsurance basis & are marketed by the Company itself & through a network of independent & affiliated agents & brokers. HCC's principal insurance company subsidiaries are Houston Casualty Co. U.S. Specialty Insurance Co. & Trafalgar Insurance Co. in Houston Texas; & AVEMCO Insurance Co. in Frederick Maryland. Hcc Insurance Holdings Inc. has a market cap of $3.03 billion; its shares were traded at around $26.95 with a P/E ratio of 9.46 and P/S ratio of 1.33. The dividend yield of Hcc Insurance Holdings Inc. stocks is 1.86%. Hcc Insurance Holdings Inc. had an annual average earning growth of 15.5% over the past 10 years. GuruFocus rated Hcc Insurance Holdings Inc. the business predictability rank of 2.5-star.
On August 4, HCC Insurance Holdings, Inc. released earnings for the second quarter ended June 30, 2009. Net earnings for the second quarter of 2009 were $91.6 million, or $0.81 per diluted share, compared to$91.7 million, or $0.79 per diluted share for the second quarter of 2008.
HCC Insurance Holdings Inc. is in the portfolios of Third Avenue Management, NWQ Managers of NWQ Investment Management Co., John Rogers of Ariel Capital Management LLC, John Keeley of Keeley Fund Management, and David Dreman of Dreman Value Management.
Last week, Buy: Director Robert A Rosholt bought 9,400 shares of HCC stock and Sell: Executive Vice President Edward H Jr Ellis sold 30,000 shares. The price has increased over 2% since. Buy: Director James E Oesterreicher bought 500 shares in August.
Chico's FAS Inc. (CHS): Director John W Burden Bought 10,000 Shares
Director of Chico's FAS Inc., John W Burden, bought 10,000 shares on 09/08/2009 at an average price of $13.38.
Chico’s FAS Inc. is a specialty retailer of exclusively designed, private label, casual clothing and related accessories. Each store offers collections of color-coordinated tops, pants, shorts, skirts, and more. Chico's Fas Inc. has a market cap of $2.37 billion; its shares were traded at around $13.38 with a P/E ratio of 167.25 and P/S ratio of 1.5. Chico's Fas Inc. had an annual average earning growth of 38.5% over the past 10 years. GuruFocus rated Chico's Fas Inc. the business predictability rank of 2.5-star.
On August 6, Chico's FAS, Inc. reported net sales for the thirteen-week period ended August 1, 2009 reached $419.9 million, compared to $405.2 million reported for the thirteen-week period ended August 2, 2008. Comparable store sales for the 2009 second quarter increased 1.3% versus the 15.9% decrease for the 2008 period. Direct-to-consumer sales, which are not included in comparable store sales, increased 46% over second quarter 2008.
Chico's FAS Inc. is in the portfolios of Lee Ainslie of Maverick Capital, PRIMECAP Management of PRIMECAP Management, Richard Snow of Snow Capital Management, L.P., and Arnold Schneider of Schneider Capital Management.Â
[ b]Buy:[/b] EVP- CFO Kent A Kleeberger bought 3,000 shares of CHS stock in March, and the price of the stock has more than tripled. Buy: Director John W Burden has been buying shares since June; Buy: Director Ross E Roeder and Buy: EVP - COO Jeffrey A Jones both also bought shares in March.
Valeant Pharmaceuticals International (VRX): Director Stephen F. Stefano Bought 2,875 Shares
Director of Valeant Pharmaceuticals International, Stephen F. Stefano, bought 2,875 shares on 9/04/2009 at an average price of $26.41.
Valeant Pharmaceuticals International is a global, publicly traded, research-based, specialty pharmaceutical company that discovers, develops, manufactures, and markets a broad range of pharmaceutical products. Valeant Pharmaceuticals International has a market cap of $2.15 billion; its shares were traded at around $26.41 with a P/E ratio of 16.51 and P/S ratio of 3.27. Valeant Pharmaceuticals International had an annual average earning growth of 2.9% over the past 5 years .
On Aug 4, Valeant Pharmaceuticals International announced second quarter financial results for 2009. Total revenue was $191.7 million in the second quarter of 2009 as compared to $153.6 million in the second quarter of 2008, an increase of 25%.
Jean-Marie Eveillard owns 1,533,650 shares of Valeant Pharmaceuticals International, which accounts for 0.44% of the $8.91 billion portfolio of Arnhold & S. Bleichroeder Advisers, LLC.
In May, Buy: CEO and Chairman of the Board J. Michael Pearson bought 7,000 shares of VRX stock and the price of the stock has increased by 42.68% since. Buy: Director Stephen F. Stefano bought 2,875 shares last week; Buy: COO Silva Rajiv De and Buy: President Bhaskar Chaudhuri bought shares in August, and Buy: Holdings, L.p. Valueact bought 39,400 shares in July.
Applied Signal Technology Inc. (APSG): Director Marie S Minton Bought 1,500 Shares
Director of Applied Signal Technology Inc., Marie S Minton, bought 1,500 shares on 9/09/2009 at an average price of $22.08.
Applied Signal Technology Inc. designs, develops, and manufactures signal processing equipment to collect and process a wide range of telecommunication signals. This equipment is used for reconnaissance of foreign telecommunications, predominantly by the United States Government and allied foreign governments for certain industrial applications and for defense communications systems. Applied Signal Technology Inc. has a market cap of $288.67 million; its shares were traded at around $22.08 with a P/E ratio of 21.44 and P/S ratio of 1.55. The dividend yield of Applied Signal Technology Inc. stocks is 2.26%.
On September 1, Applied Signal Technology, Inc. announced operating results for the third quarter of fiscal 2009, ended July 31, 2009. Revenues for the third quarter wer $49,500,000versus the year-ago quarter’s revenues of $49,948,000. Operating income for the third quarter of fiscal 2009 increased by 51% to $4,844,000, a margin of 9.8%, as compared to $3,218,000, a margin of 6.4%.
Last week, Buy: Director Marie S Minton bought 1,500 shares of APSG stock; the price of the stock has increased by 0.45% since. Sell: EVP-Broadband Com System Fred Roscher sold 1,593 shares in June; the price has decreased over 11%.
For the complete list of stocks that bought by their company executives, go to: Insider Buys.
Stericycle Inc. (SRCL): Director Rodney F Dammeyer Bought 1,200 Shares
Director of Stericycle Inc., Rodney F Dammeyer, bought 1,200 shares on 9/04/2009 at an average price of $48.43.
Stericy cle Inc. is a multi-regional integrated company employing proprietary technology to provide environmentally-responsiblemanagement of regulated medical waste for the health care industry. The Company is the second-largest provider of regulated medical waste management services in the United States. Stericycle Inc. has a market cap of $4.12 billion; its shares were traded at around $48.43 with a P/E ratio of 25.62 and P/S ratio of 3.8. Stericycle Inc. had an annual average earning growth of 41.8% over the past 10 years. GuruFocus rated Stericycle Inc. the business predictability rank of 2.5-star.
On July 28, Stericycle, Inc. reported financial results for the second quarter of 2009. Revenues for the quarter ending June 30, 2009 were $289.3 million, up 4.1% from $277.8 million in the same quarter last year. Net income for the second quarter of 2009 was $43.9 million or $0.51 per diluted share compared with net income of $38.7 millionor $0.44 per diluted share for the second quarter of 2008.
Stericycle Inc. is in the portfolios of Ron Baron of Baron Funds and Ruane Cunniff of Ruane & Cunniff & Goldfarb Inc.
Sell: CFO Brink Frank Jm Ten has been selling shares of SRCL stock since June. Buy: Director Rodney F Dammeyer bought 1,200 shares of SRCL stock last week and has been buying since last month. Sell: COO Richard T Kogler sold 11,000 shares of SRCL stock in July; the price decreased over 5%.
HCC Insurance Holdings Inc. (HCC): Director Robert A Rosholt Bought 9,400 Shares
Director of HCC Insurance Holdings Inc., Robert A Rosholt, bought 9,400 shares on 9/08/2009 at an average price of $26.95.
HCC through its subsidiaries provides specialized property & casualty insurance coverages managing general agency services & insurance related services both to commercial customers & individuals. HCC's insurance products are underwritten on both a direct & reinsurance basis & are marketed by the Company itself & through a network of independent & affiliated agents & brokers. HCC's principal insurance company subsidiaries are Houston Casualty Co. U.S. Specialty Insurance Co. & Trafalgar Insurance Co. in Houston Texas; & AVEMCO Insurance Co. in Frederick Maryland. Hcc Insurance Holdings Inc. has a market cap of $3.03 billion; its shares were traded at around $26.95 with a P/E ratio of 9.46 and P/S ratio of 1.33. The dividend yield of Hcc Insurance Holdings Inc. stocks is 1.86%. Hcc Insurance Holdings Inc. had an annual average earning growth of 15.5% over the past 10 years. GuruFocus rated Hcc Insurance Holdings Inc. the business predictability rank of 2.5-star.
On August 4, HCC Insurance Holdings, Inc. released earnings for the second quarter ended June 30, 2009. Net earnings for the second quarter of 2009 were $91.6 million, or $0.81 per diluted share, compared to$91.7 million, or $0.79 per diluted share for the second quarter of 2008.
HCC Insurance Holdings Inc. is in the portfolios of Third Avenue Management, NWQ Managers of NWQ Investment Management Co., John Rogers of Ariel Capital Management LLC, John Keeley of Keeley Fund Management, and David Dreman of Dreman Value Management.
Last week, Buy: Director Robert A Rosholt bought 9,400 shares of HCC stock and Sell: Executive Vice President Edward H Jr Ellis sold 30,000 shares. The price has increased over 2% since. Buy: Director James E Oesterreicher bought 500 shares in August.
Chico's FAS Inc. (CHS): Director John W Burden Bought 10,000 Shares
Director of Chico's FAS Inc., John W Burden, bought 10,000 shares on 09/08/2009 at an average price of $13.38.
Chico’s FAS Inc. is a specialty retailer of exclusively designed, private label, casual clothing and related accessories. Each store offers collections of color-coordinated tops, pants, shorts, skirts, and more. Chico's Fas Inc. has a market cap of $2.37 billion; its shares were traded at around $13.38 with a P/E ratio of 167.25 and P/S ratio of 1.5. Chico's Fas Inc. had an annual average earning growth of 38.5% over the past 10 years. GuruFocus rated Chico's Fas Inc. the business predictability rank of 2.5-star.
On August 6, Chico's FAS, Inc. reported net sales for the thirteen-week period ended August 1, 2009 reached $419.9 million, compared to $405.2 million reported for the thirteen-week period ended August 2, 2008. Comparable store sales for the 2009 second quarter increased 1.3% versus the 15.9% decrease for the 2008 period. Direct-to-consumer sales, which are not included in comparable store sales, increased 46% over second quarter 2008.
Chico's FAS Inc. is in the portfolios of Lee Ainslie of Maverick Capital, PRIMECAP Management of PRIMECAP Management, Richard Snow of Snow Capital Management, L.P., and Arnold Schneider of Schneider Capital Management.Â
[ b]Buy:[/b] EVP- CFO Kent A Kleeberger bought 3,000 shares of CHS stock in March, and the price of the stock has more than tripled. Buy: Director John W Burden has been buying shares since June; Buy: Director Ross E Roeder and Buy: EVP - COO Jeffrey A Jones both also bought shares in March.
Valeant Pharmaceuticals International (VRX): Director Stephen F. Stefano Bought 2,875 Shares
Director of Valeant Pharmaceuticals International, Stephen F. Stefano, bought 2,875 shares on 9/04/2009 at an average price of $26.41.
Valeant Pharmaceuticals International is a global, publicly traded, research-based, specialty pharmaceutical company that discovers, develops, manufactures, and markets a broad range of pharmaceutical products. Valeant Pharmaceuticals International has a market cap of $2.15 billion; its shares were traded at around $26.41 with a P/E ratio of 16.51 and P/S ratio of 3.27. Valeant Pharmaceuticals International had an annual average earning growth of 2.9% over the past 5 years .
On Aug 4, Valeant Pharmaceuticals International announced second quarter financial results for 2009. Total revenue was $191.7 million in the second quarter of 2009 as compared to $153.6 million in the second quarter of 2008, an increase of 25%.
Jean-Marie Eveillard owns 1,533,650 shares of Valeant Pharmaceuticals International, which accounts for 0.44% of the $8.91 billion portfolio of Arnhold & S. Bleichroeder Advisers, LLC.
In May, Buy: CEO and Chairman of the Board J. Michael Pearson bought 7,000 shares of VRX stock and the price of the stock has increased by 42.68% since. Buy: Director Stephen F. Stefano bought 2,875 shares last week; Buy: COO Silva Rajiv De and Buy: President Bhaskar Chaudhuri bought shares in August, and Buy: Holdings, L.p. Valueact bought 39,400 shares in July.
Applied Signal Technology Inc. (APSG): Director Marie S Minton Bought 1,500 Shares
Director of Applied Signal Technology Inc., Marie S Minton, bought 1,500 shares on 9/09/2009 at an average price of $22.08.
Applied Signal Technology Inc. designs, develops, and manufactures signal processing equipment to collect and process a wide range of telecommunication signals. This equipment is used for reconnaissance of foreign telecommunications, predominantly by the United States Government and allied foreign governments for certain industrial applications and for defense communications systems. Applied Signal Technology Inc. has a market cap of $288.67 million; its shares were traded at around $22.08 with a P/E ratio of 21.44 and P/S ratio of 1.55. The dividend yield of Applied Signal Technology Inc. stocks is 2.26%.
On September 1, Applied Signal Technology, Inc. announced operating results for the third quarter of fiscal 2009, ended July 31, 2009. Revenues for the third quarter wer $49,500,000versus the year-ago quarter’s revenues of $49,948,000. Operating income for the third quarter of fiscal 2009 increased by 51% to $4,844,000, a margin of 9.8%, as compared to $3,218,000, a margin of 6.4%.
Last week, Buy: Director Marie S Minton bought 1,500 shares of APSG stock; the price of the stock has increased by 0.45% since. Sell: EVP-Broadband Com System Fred Roscher sold 1,593 shares in June; the price has decreased over 11%.
For the complete list of stocks that bought by their company executives, go to: Insider Buys.
